These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16887900)

  • 1. Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T->C gene variation.
    Guardiola M; Ferré R; Salazar J; Alonso-Villaverde C; Coll B; Parra S; Masana L; Ribalta J
    Clin Chem; 2006 Oct; 52(10):1914-9. PubMed ID: 16887900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.
    Périard D; Telenti A; Sudre P; Cheseaux JJ; Halfon P; Reymond MJ; Marcovina SM; Glauser MP; Nicod P; Darioli R; Mooser V
    Circulation; 1999 Aug; 100(7):700-5. PubMed ID: 10449690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A5 gene polymorphism -1131T-->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese.
    Yan SK; Cheng XQ; Song YH; Xiao XH; Bi N; Chen BS
    Clin Chem Lab Med; 2005; 43(6):607-12. PubMed ID: 16006256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of plasma lipids during weight reduction in females depends on APOA5 variants.
    Suchanek P; Lorenzova A; Poledne R; Hubacek JA
    Ann Nutr Metab; 2008; 53(2):104-8. PubMed ID: 18946207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia.
    Evans D; Buchwald A; Beil FU
    J Mol Med (Berl); 2003 Oct; 81(10):645-54. PubMed ID: 12937897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
    Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
    Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
    Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
    J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
    Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
    Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of APOA5 -1131T>C polymorphism and serum lipid levels in patients with type 2 diabetes.
    Celap I; Simundic AM; Nikolac N; Kackov S; Katalinic D
    DNA Cell Biol; 2013 Oct; 32(10):589-93. PubMed ID: 23919616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction.
    De Caterina R; Talmud PJ; Merlini PA; Foco L; Pastorino R; Altshuler D; Mauri F; Peyvandi F; Lina D; Kathiresan S; Bernardinelli L; Ardissino D;
    Atherosclerosis; 2011 Feb; 214(2):397-403. PubMed ID: 21130994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOA5 variant Ser19Trp influences a decrease of the total cholesterol in a male 8 year cohort.
    Hubacek JA; Skodová Z; Adámková V; Lánská V; Pitha J
    Clin Biochem; 2006 Feb; 39(2):133-6. PubMed ID: 16386723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
    Keiser PH; Sension MG; DeJesus E; Rodriguez A; Olliffe JF; Williams VC; Wakeford JH; Snidow JW; Shachoy-Clark AD; Fleming JW; Pakes GE; Hernandez JE;
    BMC Infect Dis; 2005 Jan; 5():2. PubMed ID: 15647105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
    ; Sarwar N; Sandhu MS; Ricketts SL; Butterworth AS; Di Angelantonio E; Boekholdt SM; Ouwehand W; Watkins H; Samani NJ; Saleheen D; Lawlor D; Reilly MP; Hingorani AD; Talmud PJ; Danesh J
    Lancet; 2010 May; 375(9726):1634-9. PubMed ID: 20452521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
    Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
    Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
    van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
    Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked dyslipidemia in human immunodeficiency virus-infected children on protease inhibitor-containing antiretroviral therapy.
    Lainka E; Oezbek S; Falck M; Ndagijimana J; Niehues T
    Pediatrics; 2002 Nov; 110(5):e56. PubMed ID: 12415062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia.
    Sousa MO; Alía P; Pintó X; Corbella E; Navarro MA
    Clin Chim Acta; 2008 Sep; 395(1-2):68-71. PubMed ID: 18549811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.